Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Ilaria Palma"'
Autor:
Cecilia Calabrese, Anna Annunziata, Martina Flora, Domenica Francesca Mariniello, Valentino Allocca, Maria Ilaria Palma, Antonietta Coppola, Ilernando Meoli, Pia Clara Pafundi, Giuseppe Fiorentino
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2022)
Background: Previous studies have demonstrated persistent dyspnoea and impairment of respiratory function in the follow-up of patients who have recovered from COVID-19 pneumonia. However, no studies have evaluated the clinical and functional conseque
Externí odkaz:
https://doaj.org/article/4dd1115304424c619cc467ad0fbc62b4
Autor:
Grazia Mazzeo, Luigi Aronne, Domenica Francesca Mariniello, Valentino Allocca, Maria Ilaria Palma, Francesco Saverio Cerqua, Carlo Iadevaia, Adriano Costigliola, Roberto Parrella, Andrea Bianco, Vanvitelli/Monaldi COVID Group
Publikováno v:
Monaldi Archives for Chest Disease (2021)
Identification of risk factors for severe outcome of Sars-Cov-2 infection is an important issue in COVID-19 management. Much attention has been focused on comorbidities as well as drugs taken by patients. Usage of proton pump inhibitors (PPIs) appear
Externí odkaz:
https://doaj.org/article/92af4a738bcb49428ac7a31f04604b76
Autor:
Cecilia Calabrese, Anna Annunziata, Martina Flora, Domenica Francesca Mariniello, Valentino Allocca, Maria Ilaria Palma, Antonietta Coppola, Ilernando Meoli, Pia Clara Pafundi, Giuseppe Fiorentino
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2022)
Background: Previous studies have demonstrated persistent dyspnoea and impairment of respiratory function in the follow-up of patients who have recovered from COVID-19 pneumonia. However, no studies have evaluated the clinical and functional conseque
Autor:
Francesco Saverio Cerqua, Andrea Bianco, Carlo Iadevaia, Luigi Aronne, Roberto Parrella, Maria Ilaria Palma, Adriano Costigliola, Vanvitelli, Valentino Allocca, Domenica Francesca Mariniello, Grazia Mazzeo
Publikováno v:
Monaldi Archives for Chest Disease (2021)
Identification of risk factors for severe outcome of Sars-Cov-2 infection is an important issue in COVID-19 management. Much attention has been focused on comorbidities as well as drugs taken by patients. Usage of proton pump inhibitors (PPIs) appear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98b9110f510bba8dbd28209e53b91911
https://monaldi-archives.org/index.php/macd/article/view/1803
https://monaldi-archives.org/index.php/macd/article/view/1803